Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Edwards Lifesciences Q1 2024 Adj EPS $0.66 Beats $0.64 Estimate, Sales $1.598B Beat $1.569B Estimate

Author: Benzinga Newsdesk | April 25, 2024 04:16pm
Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. The company reported quarterly sales of $1.598 billion which beat the analyst consensus estimate of $1.569 billion by 1.85 percent. This is a 9.45 percent increase over sales of $1.460 billion the same period last year.

Posted In: EW


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist